R Squared LTD Biotechnology

R Squared LTD

$103 Billion
Q4 2024

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
LXRX Lexicon Pharmaceuticals, Inc.	$100M	$2.25 Million 0.0% of portfolio	3,040	Q4 2024 New
STRO Sutro Biopharma, Inc.	$31.3M	$2.19 Million 0.0% of portfolio	1,190	Q4 2024 New
REPL Replimune Group, Inc.	$370M	$2.18 Million 0.0% of portfolio	180	Q4 2024 New
GLUE Monte Rosa Therapeutics, Inc.	$206M	$2.08 Million 0.0% of portfolio	300	Q4 2024 New
TSVT 2seventy Bio, Inc.	$188M	$2.03 Million 0.0% of portfolio	690	Q4 2024 New
MGNX Macrogenics Inc	$78.1M	$1.85 Million 0.0% of portfolio	570	Q4 2024 New
NVCT Nuvectis Pharma, Inc.	$143M	$1.68 Million 0.0% of portfolio	310	Q4 2024 New
CRVS Corvus Pharmaceuticals, Inc.	$149M	$1.55 Million 0.0% of portfolio	290	Q4 2024 New
VIGL Vigil Neuroscience, Inc.	$45.5M	$1.55 Million 0.0% of portfolio	910	Q4 2024 New
MRSN Mersana Therapeutics, Inc.	$32.1M	$1.52 Million 0.0% of portfolio	1,060	Q4 2024 New
HRTX Heron Therapeutics, Inc.	$229M	$1.52 Million 0.0% of portfolio	990	Q4 2024 New
ABCL Ab Cellera Biologics Inc.	$696M	$1.38 Million 0.0% of portfolio	470	Q4 2024 New
PYXS Pyxis Oncology, Inc.	$32.3M	$1.37 Million 0.0% of portfolio	880	Q4 2024 New
SRRK Scholar Rock Holding Corp	$1.49B	$1.3 Million 0.0% of portfolio	30	Q4 2024 New
CRDF Cardiff Oncology, Inc.	$121M	$1.26 Million 0.0% of portfolio	290	Q4 2024 New
JANX Janux Therapeutics, Inc.	$1.21B	$1.07 Million 0.0% of portfolio	20	Q4 2024 New
FATE Fate Therapeutics Inc	$89.2M	$990,000 0.0% of portfolio	600	Q4 2024 New
ATOS Atossa Therapeutics, Inc.	$79.8M	$963,000 0.0% of portfolio	1,020	Q4 2024 New
KALV Kal Vista Pharmaceuticals, Inc.	$294M	$932,000 0.0% of portfolio	110	Q4 2024 New
CABA Cabaletta Bio, Inc.	$33.9M	$863,000 0.0% of portfolio	380	Q4 2024 New
NUVB Nuvation Bio Inc.	$439M	$798,000 0.0% of portfolio	300	Q4 2024 New
BCAB Bio Atla, Inc.	$11.6M	$733,000 0.0% of portfolio	1,240	Q4 2024 New
VNDA Vanda Pharmaceuticals Inc.	$247M	$671,000 0.0% of portfolio	140	Q4 2024 New
VERU Veru Inc.	$44.1M	$618,000 0.0% of portfolio	950	Q4 2024 New
PDSB Pds Biotechnology Corp	$30.7M	$489,000 0.0% of portfolio	300	Q4 2024 New
CAPR Capricor Therapeutics, Inc.	$229M	$414,000 0.0% of portfolio	30	Q4 2024 New
ALLO Allogene Therapeutics, Inc.	$206M	$234,000 0.0% of portfolio	110	Q4 2024 New
TSHA Taysha Gene Therapies, Inc.	$61.9M	$225,000 0.0% of portfolio	130	Q4 2024 New
CHRS Coherus Bio Sciences, Inc.	$75.4M	$193,000 0.0% of portfolio	140	Q4 2024 New
TPST Tempest Therapeutics, Inc.	$77M	$159,000 0.0% of portfolio	190	Q4 2024 New
TARA Protara Therapeutics, Inc.	$47.4M	$158,000 0.0% of portfolio	30	Q4 2024 New
FHTX Foghorn Therapeutics Inc.	$149M	$142,000 0.0% of portfolio	30	Q4 2024 New
RVPH Reviva Pharmaceuticals Holdings, Inc.	$15.5M	$54,000 0.0% of portfolio	30	Q4 2024 New

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of R Squared LTD, based on Form 13F filings with the SEC.

News

Stay updated on R Squared LTD with notifications on news.